Can Big Data/Real World Data Cure
Life Science’s R&D Malaise?
Glen de Vries
Founder and President
© 2014 Medidata Solutions, Inc.
Regulators
Payers
Efficacy
Data
Effectiveness
Data
Development
Commercial
© 2014 Medidata Solutions, Inc.
Regulators
Payers
The
Same
Data
Development
Commercial
© 2014 Medidata Solutions, Inc.
*omics
Clinical
mHealth
© 2014 Medidata Solutions, Inc.
•MEDIDATA, AN INTRODUCTION
6
ENGAGE, COLLABORATE, INNOVATE
+
The GADGET Method Development Effort
© 2014 Medidata Solutions, Inc.
© 2014 Medidata Solutions, Inc.
Genetic
Biomarkers
Phenotypic
Biomarkers
Digital
Biomarkers
© 2014 Medidata Solutions, Inc.
12
13
The Medidata MOVE-2014 Study
© 2014 Medidata Solutions, Inc.
Objections
Privacy
Safety
Regulation
© 2014 Medidata Solutions, Inc.
© 2014 Medidata Solutions, Inc.
Value (Therapeutic & Economic)
Approval
Patent Expiration
Clinical Development
Patient Engagement
Strategy
Commercial Patient
Engagement
Strategy
Baseline Value
£350 Billion lost annually from
+
patients not taking their
medicines
Therapeutic
Benefits!
Time
© 2014 Medidata Solutions, Inc.
2020 Predictions
There will be life sciences companies using
objectively measured digital biomarker data with
both regulators and payers…
And there will still be life sciences companies
that are not
© 2014 Medidata Solutions, Inc.
10 years from now life sciences
companies that don’t use digital
biomarkers as part of their
solutions will no longer exist
© 2014 Medidata Solutions, Inc.
Thank you!
© 2014 Medidata Solutions, Inc.